Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 19, 2024Current Problems in Cancer Case ReportsOpen Access

Advanced non-small cell lung cancer patient with a complete response and allergic immune-related adverse events by combined immunotherapy, including anti-CTLA-4 and anti-PD-1 antibodies: A case report

View Full Paper
Ask AI
Bookmark
Share

Authors

CNChiho NakashimaSaga UniversityYKYuki KuwaharaSaga UniversitySKS KitamuraSaga University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nakashima et al. (2024) studied this question.

synapsesocial.com/papers/68e696fcb6db64358761d3bahttps://doi.org/10.1016/j.cpccr.2024.100298
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer2019 · 59 citations
  2. 2Eosinophils: The unsung heroes in cancer?2017 · 288 citations
  3. 3A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer2022 · 14 citations
  4. 4Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer2019 · 2,914 citations